Industry Uptake Research Articles

How Do We Accelerate Uptake and Fulfill the Value Potential of Intelligent Energy?

Summary The objective of this paper is to identify ways to accelerate the uptake and fulfill the value potential of Intelligent Energy (IE). The paper is coauthored by a cross-industry group drawn from operators, service providers, and product vendors, all of whom have been involved in the IE arena for 10 years or more. We have analyzed past experiences to identify both ways in which IE has been successful and the improvements that could be made to add value across a broader scale amid the challenges of today's commercial environment. In this paper, assessments are given on IE implementations to identify practical ways in which we can expand deployment and deliver results more quickly, including the importance of collaboration and competition in the IE domain, and how longer-term business models and new organizational ideas could improve the industry's uptake of IE. We have identified two areas in which we believe changes to our approach could deliver significant benefits—through the expanded use of integrated work flows and shared subject-matter-expert (SME) services. We discuss the benefits and challenges of this integrated approach to solution design, work processes, technology, skills, and competencies. Field cases from two major operators are given as best-practice examples on advanced use of IE in the oil-and-gas industry.

The practice and perception of precautionary allergen labelling by the Australasian food manufacturing industry.

The precautionary allergen labelling (PAL) and Voluntary Incidental Trace Allergen Labelling (VITAL® ) tools were designed by industry to assist consumers with selecting safe foods for consumption. However, a sizeable proportion of food products bear no label, and it is unclear whether these products are free from allergens and therefore safe to consume or have simply not undergone a risk assessment and therefore remain unlabelled for that reason. To assess the prevalence of unlabelled products that have undergone a risk assessment process and to examine the factors influencing industry's uptake of the VITAL® process. A web-based questionnaire was distributed to Australasian food and grocery manufacturers. One hundred and thirty-seven Australasian manufacturers were contacted, and 59 questionnaires were returned (response rate: 43%). The respondents represented 454 different manufacturing sites. Manufacturers reported that 23% (95% CI 19-28) of products (n=102/434) that had been through the VITAL® risk assessment process had no PAL statement on the label. 34% (95% CI 30-38), (n=204/600) of products that had undergone another (non-VITAL® ) risk assessment process had no PAL statement. In examining the factors that influenced industry's uptake of the VITAL® process, 25 manufacturers reported on factors that influenced the uptake of the VITAL® process, 76% (CI 95% 55-91) reported that VITAL® was an effective tool because it was based on science; 52% (CI 95% 31-72) reported that it was too time-consuming and 36% (CI 95% 18-57) identified a concern with it not being endorsed by the government. Currently, we estimate that at least 30% of products may have been through a risk assessment process and yet bear no PAL statement on the label. Permissive labelling could be incorporated onto these products if they have been assessed to be safe for consumption.